Tag Archives: TAP

Top Biotech Stocks To Invest In 2022

Amyris  (AMRS) – Get Report shares soared Friday after the biotech company announced promising in vivo results for a study of its licensed RNA vaccine for COVID through intranasal delivery.

The vaccine is being developed in collaboration with the Infectious Disease Research Institute, Amyris said.

Amyris recently traded at $13.67, up 13%.

“Current mRNA vaccine technologies are providing limited immunity protection for the upper respiratory system,” Amyris said. “As a result, vaccinated people may experience viral replication and viral shedding regardless of variants.”

TheStreet RecommendsPRESS RELEASESPayPal Launches The Ability To Buy, Hold And Sell Cryptocurrency In The UK14 minutes agoPRESS RELEASESAMG Advanced Metallurgical Group N.V. Responds To Press Reports Regarding Its Lithium Activities15 minutes agoPRESS RELEASESAMG Advanced Metallurgical Group N.V. Announces The Construction Of Its First Lithium Vanadium Battery For Industrial Power Management Applications15 minutes ago

But “in vivo results indicate that, when delivered to the mucosal membranes via intranasal administration, the Amyris/IDRI RNA vaccine generates antibodies and provides upper respiratory protection for COVID-19.”

Top Biotech Stocks To Invest In 2022: Molson Coors Brewing Company(TAP)

Molson Coors Brewing Company brews, markets, sells, and distributes beer brands. It sells its products in Canada, under the Coors Light, Molson, Rickard’s Red, Carling, Pilsner, Keystone Light, Creemore Springs, and Granville Island brands. The company also brews or distributes products under license from third parties, which include Heineken, Amstel Light, Murphy’s, Asahi, Asahi Select, Miller Lite, Miller Genuine Draft, Miller Chill, Milwaukee’s Best, Milwaukee’s Best Dry, and Foster’s. In addition, it imports, distributes, and markets the Corona, Coronita, Negra Modelo, and Pacifico brands, through a joint venture agreement with Grupo Modelo. Further, the company sells various brands in the United States, which include Coors Light, Miller Lite, Coors Banquet, Miller Genuine Draft, MGD 64, Miller Chill, Sparks, Miller High Life, Miller High Life Light, Keystone Light, Icehouse, Mickey’s, Milwaukee’s Best, Milwaukee’s Best Light, Old English 800, Blue Moon, Henry Weinhard ‘s, George Killian’s Irish Red, Leinenkugel’s, Peroni Nastro Azzurro, Pilsner Urquell, Grolsch, Coors Non-Alcoholic, and Sharp’s. Additionally, it sells various brands in the United Kingdom comprising Carling, C2, Coors Light, Worthington’s, White Shield, Caffrey’s, Kasteel Cru, and Blue Moon, as well as various regional ale brands. The company also sells the Grolsch brands through a joint venture with Royal Grolsch N.V. and the Cobra brands through a joint venture called Cobra Beer Partnership Ltd.; and distributes brands sold under license, including Corona, Coronita, Negra Modelo, Pacfico, Singha, and Magners Draught Cider. In addition, it markets and sells Zima, Si’hai, Coors Gold, and Coors Extra brands to various international markets. The company was formerly known as Adolph Coors Company and changed its name to Molson Coors Brewing Company as a result of its merger with Molson Inc. in February 2005. Molson Coors Brewing Company was founded in 1873 and is headquartere d in Denver, Colorado.

Advisors’ Opinion:

  • [By Todd Campbell]

    One big driver of HEXO’s future success could be cannabis-based consumer products, including beverages. In 2018, Molson Coors (NYSE:TAP) and HEXO launched a joint venture 57.5% owned by Molson Coors to develop non-alcoholic cannabis beverages for Canada’s recreational market. However, those beverages can’t be sold in Canada until regulators agree. There’s no word on when Canada will green light other cannabis products, but industry watchers widely believe a decision will be made in 2019.

  • [By Sean Williams]

    There may also be concern that HEXO’s joint venture with Molson Coors Brewing (NYSE:TAP) may not yield the desired results due to increasing competition in the nonalcoholic cannabis-infused beverage space. Although the joint venture (known as Truss) between Molson Coors and HEXO was announced in August 2018, these products won’t be legally allowed for sale until probably October 2019. This gap gave Molson Coors’ and HEXO’s competition ample time to catch up, meaning it may not be the needle mover that investors have been expecting.

Top Biotech Stocks To Invest In 2022: Chemung Financial Corp(CHMG)

Chemung Financial Corporation, incorporated on January 2, 1985, is a bank holding company. The Company, through its subsidiaries, Chemung Canal Trust Company (the Bank) and CFS Group, Inc. (CFS), provides a range of banking, financing, fiduciary and other financial services to its clients. The Company manages its operations through two segments: core banking and Wealth Management Group (WMG). The core banking segment receives deposits from the general public and uses such funds to originate consumer, commercial, commercial real estate and residential mortgage loans, mainly in its local markets and to invest in securities. The WMG services segment provides trust and investment advisory services to clients. The Company’s financial services include demand, savings and time deposits, commercial, residential and consumer loans, interest rate swaps, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds and brokerage services. The Bank operates approximately 30 branch offices located in over 10 counties in New York and Bradford County in Pennsylvania. The Bank also operates under the name of its division, Capital Bank, with branch offices located in Albany and Saratoga counties in New York. The Bank provides wealth management services as executor and trustee under wills and agreements, and guardian, custodian, trustee and agent for pension, profit-sharing and other employee benefit trusts, as well as various investment, pension, estate planning and employee benefit administrative services.

Lending Activities

The Company divides its loan portfolio into lending categories: commercial and agricultural, commercial mortgages, residential mortgages and consumer loans. Commercial and agricultural loans consist of loans to small to mid-sized businesses in its market area in a diverse range of industries. The Company also provides commercial mortgage loans. It offers interest rate swaps to certain commercial mortgage borrowers. The residentia! l mortgage loans are made on the basis of the borrower’s ability to make repayment from his or her employment and other income but are secured by real property. The consumer loans include home equity lines of credit and home equity loans. The Company’s total loans are approximately $1,168.63 million.

Investment Activities

The Company’s investments include securities available for sale and securities held to maturity. The Company’s securities available for sale include obligations of the United States Government, obligations of the United States Government sponsored enterprises, mortgage-backed securities, residential and collateralized mortgage obligations, obligations of states and political subdivisions, and other securities. The Company’s total available for sale securities are approximately $344.8 million. The Company’s securities held to maturity consist of obligations of political subdivisions in its market areas. The Company’s total held to maturity securities are approximately $4.6 million. Its non-marketable equity securities include shares of Federal Reserve Bank of New York (FRBNY) stock and Federal Home Loan Bank of New York (FHLBNY) stock.

Sources of Funds

The Company’s sources of funds are deposits, principal and interest payments on loans and securities, borrowings and funds generated from operations of the Bank. The Bank also has access to advances from the FHLBNY, other financial institutions and the FRBNY. The Company’s deposits consist of non-interest-bearing and interest-bearing checking accounts, savings accounts, insured money market accounts and Time deposits. The Company’s total deposits are approximately $1,400 million.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Southside Bancshares (NASDAQ:SBSI) and Chemung Financial (NASDAQ:CHMG) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.

  • [By Ethan Ryder]

    Chemung Financial Corp. (NASDAQ:CHMG) Director Robert H. Dalrymple sold 2,000 shares of the business’s stock in a transaction dated Tuesday, August 21st. The stock was sold at an average price of $42.54, for a total transaction of $85,080.00. Following the completion of the transaction, the director now directly owns 237,541 shares of the company’s stock, valued at $10,104,994.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Chemung Financial (CHMG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Chemung Financial (CHMG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Biotech Stocks To Invest In 2022: NovoCure Limited(NVCR)

NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.

Advisors’ Opinion:

  • [By Brian Feroldi]

    Medical device makers were some of the best-performing companies on the market last year. In this week’s episode of Industry Focus: Healthcare, host Shannon Jones and Motley Fool contributor Brian Feroldi talk about three medical device monopolies that investors might want to take a closer look at. Listen and find out what makes Intuitive Surgical(NASDAQ:ISRG), Abiomed(NASDAQ:ABMD), and NovoCure (NASDAQ:NVCR)stand out from the crowd, dominate their niches, and improve patient lives. Plus, learn the key metrics investors should watch, what long-term risks to be aware of, which of the companies faces the most competitive risk, some of the most exciting opportunities still ahead, and more.

  • [By Ethan Ryder]

    Novocure (NASDAQ:NVCR) and Anika Therapeutics (NASDAQ:ANIK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.